Platelet-derived growth factor compositions and methods of use thereof
View Patent ↗A method for promoting growth of bone, periodontium, ligament, or cartilage in a mammal by applying to the bone, periodontium, ligament, or cartilage a composition comprising platelet-derived growth factor at a concentration in the range of about 0.1 mg/mL to about 1.0 mg/mL in a pharmaceutically acceptable liquid carrier and a pharmaceutically-acceptable solid carrier.
1. An implant material consisting of a porous calcium phosphate having incorporated therein a liquid consisting of platelet derived growth factor (PDGF) at a concentration in a range of about 0.1 mg/mL to about 1.0 mg/mL in a buffer, wherein the calcium phosphate has interconnected pores, a porosity greater than 40%, and consists of particles in a range of about 100 microns to about 5000 microns in size.
2. The implant material of claim 1 wherein the PDGF is recombinant PDGF.
3. The implant material of claim 1 wherein the PDGF is recombinant PDGF-BB.
4. The implant material of claim 1 wherein the liquid consists of PDGF at a concentration of about 0.3 mg/mL in a buffer.
5. The implant material of claim 1 wherein the liquid consists of PDGF at a concentration in a range of about 0.25 mg/mL to about 0.5 mg/mL in a buffer.
6. The implant material of claim 1 wherein the calcium phosphate is tricalcium phosphate.
7. The implant material of claim 1 wherein the calcium phosphate consists of particles in a range of about 100 microns to about 3000 microns in size.
8. The implant material of claim 1 wherein the calcium phosphate consists of particles in a range of about 250 microns to about 1000 microns in size.
9. The implant material of claim 1 wherein the implant material is resorbable such that at least 80% of the calcium phosphate is resorbed within one year of being implanted.
10. The implant material of claim 1 wherein the incorporated liquid is adsorbed or absorbed to the calcium phosphate.
11. An implant material consisting of a calcium phosphate having incorporated therein a liquid consisting of platelet derived growth factor (PDGF) at a concentration in a range of about 0.1 mg/mL to about 1.0 mg/mL in a buffer, wherein the implant material is a composition having a porosity that facilitates cell migration into the composition and the calcium phosphate has interconnected pores and consists of particles in a range of about 100 microns to about 5000 microns in size.
12. The implant material of claim 11 wherein said porosity is macroporosity.
13. The implant material of claim 11 wherein said porosity consists of porous calcium phosphate particles having a porosity greater than 40%.
14. The implant material of claim 11 wherein the PDGF is recombinant human (rh) PDGF-BB.
15. The implant material of claim 11 wherein the calcium phosphate is tricalcium phosphate.
16. The implant material of claim 11 wherein the calcium phosphate consists of particles in a range of about 100 microns to about 3000 microns in size.
17. The implant material of claim 11 wherein the calcium phosphate consists of particles in a range of about 250 microns to about 2000 microns in size.
18. The implant material of claim 11 wherein the calcium phosphate consists of particles in a range of about 250 microns to about 1000 microns in size.
19. The implant material of claim 11 wherein the liquid consists of PDGF at a concentration of about 0.3 mg/mL in a buffer.
20. The implant material of claim 11 wherein the liquid consists of PDGF at a concentration in a range of about 0.25 mg/mL to about 0.5 mg/mL in a buffer.
21. The implant material of claim 11 wherein the liquid consists of PDGF at a concentration in a range of about 0.2 mg/mL to about 0.75 mg/mL in a buffer.
22. The implant material of claim 11 wherein the implant material is resorbable such that at least 80% of the calcium phosphate is resorbed within one year of being implanted.
23. An implant material consisting of collagen and a porous calcium phosphate having incorporated therein a liquid consisting of platelet derived growth factor (PDGF) at a concentration in a range of about 0.1 mg/mL to about 1.0 mg/mL in a buffer, wherein the calcium phosphate has interconnected pores, a porosity greater than 40%, and consists of particles in a range of about 100 microns to about 5000 microns in size.
24. The implant material of claim 23 wherein the PDGF is recombinant human (rh) PDGF-BB and the calcium phosphate is tricalcium phosphate.
25. The implant material of claim 23 wherein the calcium phosphate consists of particles in a range of about 100 microns to about 3000 microns in size.
26. The implant material of claim 23 wherein the calcium phosphate consists of particles in a range of about 250 microns to about 1000 microns in size.
27. The implant material of claim 23 wherein the liquid consists of PDGF at a concentration of about 0.3 mg/mL in a buffer.
28. The implant material of claim 23 wherein the implant material is resorbable such that at least 80% of the calcium phosphate is resorbed within one year of being implanted.
29. An implant material consisting of collagen and a calcium phosphate having incorporated therein a liquid consisting of platelet derived growth factor (PDGF) at a concentration in a range of about 0.1 mg/mL to about 1.0 mg/mL in a buffer, wherein the implant material is a composition having a porosity that facilitates cell migration into the composition and the calcium phosphate has interconnected pores and consists of particles in a range of about 100 microns to about 5000 microns in size.
30. The implant material of claim 29 wherein said porosity is macroporosity.
31. The implant material of claim 29 wherein said porosity consists of porous calcium phosphate particles having a porosity greater than 40%.
32. The implant material of claim 29 wherein the PDGF is recombinant human (rh) PDGF-BB and the calcium phosphate is tricalcium phosphate.
33. The implant material of claim 29 wherein the calcium phosphate consists of particles in a range of about 100 microns to about 3000 microns in size.
34. The implant material of claim 29 wherein the calcium phosphate consists of particles in a range of about 250 microns to about 1000 microns in size.
35. The implant material of claim 29 wherein the liquid consists of PDGF at a concentration of about 0.3 mg/mL in a buffer.
36. An implant material consisting of a calcium phosphate having incorporated therein a liquid consisting of platelet derived growth factor (PDGF) at a concentration in a range of about 0.1 mg/mL to about 1.0 mg/mL in a buffer, wherein the calcium phosphate has interconnected pores and consists of particles in a range of about 100 microns to about 5000 microns in size, and wherein the calcium phosphate is capable of absorbing an amount of the liquid consisting of PDGF that is equal to at least about 25% of the calcium phosphate's own weight.
37. The implant material of claim 36 , wherein the calcium phosphate is capable of absorbing an amount of the liquid consisting of PDGF that is equal to at least about 50% of the calcium phosphate's own weight.
38. The implant material of claim 37 , wherein the calcium phosphate is capable of absorbing an amount of the liquid consisting of PDGF that is equal to at least about 200% of the calcium phosphate's own weight.
39. The implant material of claim 38 , wherein the calcium phosphate is capable of absorbing an amount of the liquid consisting of PDGF that is equal to at least about 300% of the calcium phosphate's own weight.
40. An implant material consisting of collagen and a calcium phosphate having incorporated therein a liquid consisting of platelet derived growth factor (PDGF) at a concentration in a range of about 0.1 mg/mL to about 1.0 mg/mL in a buffer, wherein the calcium phosphate has interconnected pores and consists of particles in a range of about 100 microns to about 5000 microns in size, and wherein the calcium phosphate and collagen are capable of absorbing an amount of the liquid consisting of PDGF that is equal to at least about 25% of the weight of the calcium phosphate and collagen.
41. The implant material of claim 40 , wherein the calcium phosphate and collagen are capable of absorbing an amount of the liquid consisting of PDGF that is equal to at least about 50% of the weight of the calcium phosphate and collagen.
42. The implant material of claim 41 , wherein the calcium phosphate and collagen are capable of absorbing an amount of the liquid consisting of PDGF that is equal to at least about 200% of the weight of the calcium phosphate and collagen.
43. The implant material of claim 42 , wherein the calcium phosphate and collagen are capable of absorbing an amount of the liquid consisting of PDGF that is equal to at least about 300% of the weight of the calcium phosphate and collagen.
44. An implant material consisting of a calcium phosphate having incorporated therein a liquid consisting of platelet derived growth factor (PDGF) at a concentration of about 0.3 mg/mL in a buffer, wherein the calcium phosphate has interconnected pores and consists of particles in a range of about 100 microns to about 5000 microns in size, and wherein the calcium phosphate is capable of absorbing an amount of the liquid consisting of PDGF that is equal to at least about 25% of the calcium phosphate's own weight.
45. An implant material consisting of collagen and a calcium phosphate having incorporated therein a liquid consisting of platelet derived growth factor (PDGF) at a concentration of about 0.3 mg/mL in a buffer, wherein the calcium phosphate has interconnected pores and consists of particles in a range of about 100 microns to about 5000 microns in size, and wherein the calcium phosphate and collagen are capable of absorbing an amount of the liquid consisting of PDGF that is equal to at least about 25% of the weight of the calcium phosphate and collagen.